CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation
about
Discovery of a proteinaceous cellular receptor for a norovirusCD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell linesIdentification and Characterization of CD300H, a New Member of the Human CD300 Immunoreceptor FamilyThe SIRP family of receptors and immune regulationEnhanced efferocytosis by dendritic cells underlies memory T-cell expansion and susceptibility to autoimmune disease in CD300f-deficient miceCutting edge: mouse CD300f (CMRF-35-like molecule-1) recognizes outer membrane-exposed phosphatidylserine and can promote phagocytosisTIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injuryCeramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activationAncient divergence of a complex family of immune-type receptor genes.Expression, crystallization and X-ray data collection from microcrystals of the extracellular domain of the human inhibitory receptor expressed on myeloid cells IREM-1.Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3.Regulation of Immune Responses by the Activating and Inhibitory Myeloid-Associate Immunoglobuline-Like Receptors (MAIR) (CD300)Recognition of additional roles for immunoglobulin domains in immune functionDisrupting ceramide-CD300f interaction prevents septic peritonitis by stimulating neutrophil recruitment.The CD300 molecules: an emerging family of regulators of the immune system.Toll-like receptor 4 and MAIR-II/CLM-4/LMIR2 immunoreceptor regulate VLA-4-mediated inflammatory monocyte migrationp85α recruitment by the CD300f phosphatidylserine receptor mediates apoptotic cell clearance required for autoimmunity suppressionDynamic changes in endothelial cell adhesion molecule nepmucin/CD300LG expression under physiological and pathological conditions.The immunoreceptor adapter protein DAP12 suppresses B lymphocyte-driven adaptive immune responses.The Receptor CMRF35-Like Molecule-1 (CLM-1) Enhances the Production of LPS-Induced Pro-Inflammatory Mediators during Microglial Activation.Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor.Nepmucin, a novel HEV sialomucin, mediates L-selectin-dependent lymphocyte rolling and promotes lymphocyte adhesion under flowRole of ITAM-containing adapter proteins and their receptors in the immune system and bone.The TREM receptor family and signal integration.Negative signaling by inhibitory receptors: the NK cell paradigm.Osteoclasts - the innate immune cells of the bone.DAP10- and DAP12-associated receptors in innate immunity.Osteoimmunology: the expanding role of immunoreceptors in osteoclasts and bone remodelingA Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.Dendritic cells expressing immunoreceptor CD300f are critical for controlling chronic gut inflammationInterleukin-33 requires CMRF35-like molecule-1 expression for induction of myeloid cell activation.SHPS-1 and a synthetic peptide representing its ITIM inhibit the MyD88, but not TRIF, pathway of TLR signaling through activation of SHP and PI3K in THP-1 cells.Synthetic peptides containing ITIM-like domains block expression of inflammatory mediators and migration/invasion of cancer cells through activation of SHP-1 and PI3K.Synthetic peptides containing ITIM-like sequences of IREM-1 (CD300F) differentially regulate MyD88 and TRIF-mediated TLR signalling through activation of SHP and/or PI3K.Synthetic peptides containing ITIM-like sequences of IREM-1 inhibit BAFF-mediated regulation of interleukin-8 expression and phagocytosis through SHP-1 and/or PI3K.BAFF and APRIL induce inflammatory activation of THP-1 cells through interaction with their conventional receptors and activation of MAPK and NF-κB.Stimulation of FasL induces production of proinflammatory mediators through activation of mitogen-activated protein kinases and nuclear factor-κB in THP-1 cells.Characterization of leukocyte mono-immunoglobulin-like receptor 7 (LMIR7)/CLM-3 as an activating receptor: its similarities to and differences from LMIR4/CLM-5.Human CD300C delivers an Fc receptor-γ-dependent activating signal in mast cells and monocytes and differs from CD300A in ligand recognition.Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin Inflammation.
P2860
Q27727711-0F50DBA6-5833-4811-AABC-620985B4E143Q28115250-03AFE292-7D61-4BA5-A4AC-E407FEFDEC8CQ28115550-5C20EEE1-0894-4BFF-885E-C62B65D308B3Q28239784-901E569B-8BF8-4A49-B185-C6D912F2DEF7Q28588565-14A3459E-C07D-44AC-8FA5-3AAD6AD43FD6Q28591345-C4D8D066-33B4-415D-81B7-ADAF9540A872Q28591447-4EF1DAA1-F48B-4F45-8AA6-93E05902181CQ28833693-CEB58357-476E-41B5-BA42-BC72397FF69BQ31043059-345B3D89-0C77-41B1-BE73-9712588FC784Q31103732-15B17599-33AE-4D3C-9867-8A03A833A96FQ31109562-88E82E9F-AD13-4B3C-AD04-4AF1800E1347Q33578095-B3666994-5973-43E4-A19A-6AA32F40D402Q33664936-A1ED30E4-CCF1-48C9-ABB1-98CC59CF4E59Q33842942-6EB7E2BB-17BC-4864-9EEA-778F67B614E4Q34035020-D6852FC4-7A36-487F-93EC-28C55D083DA7Q34086419-BC1B03BB-3334-402D-ADF3-EB12ADBFB436Q34120500-8C4F0EE9-B218-44E6-9AA1-BCE1EDB71B2BQ35078143-FC972037-9156-4AAE-8356-59CC41C4E765Q35144618-96F45D3D-F174-436C-ACFD-0A8EFBCD6E77Q35618771-65C3FCC5-82A8-4564-977A-DC674A056C71Q36131729-17BA6752-7CD8-425E-BDBC-2B18A120E702Q36228665-92983D13-48FA-42F4-BB36-29EDEDE54D64Q36324920-1AE298FE-13A4-485E-A277-F8F5F1A6804BQ36655903-0D1115EF-FFE8-406B-927A-7E88B67A3B7FQ36983705-AEE82613-C2C1-438F-A407-31DFCEB10771Q37118763-26050002-D2BF-4350-AB16-02DBFD946115Q37361459-C425ABD4-98B6-4AF5-8404-63C4560EBEB1Q38116019-D15DF47B-58E0-4FF1-8213-3A28CB3981CEQ38634916-CE163AF0-0880-47AA-8CEE-5B17B50C8AA9Q38834628-BFE8DA37-B4D7-4B22-98A9-20636A635802Q39209203-C105A7EF-A2D0-48BE-9C68-A9AC4801A6FBQ39211459-5780AFEC-A313-4D7B-8DE1-C206136D1EFBQ39351460-708D98B8-A111-4156-9412-B2F2007BADD1Q39404438-EC3B2762-0514-4BB4-AFD5-24EB2655D07BQ39478976-88A2BF26-3802-4326-9051-8608D25FF856Q39555969-8E69A65B-297E-4A3C-8C70-80D8FBD44E1AQ39620643-75DA96CA-0900-4FB6-899E-5E4688BA862BQ39659418-FDF7D222-56CD-41A3-A1B9-B423D7A056DCQ41116097-36C6A0D4-0C31-4D98-8B61-083CF43B9984Q41882434-7EEFCE9C-A29D-4214-ADF7-1A9D89C02EBC
P2860
CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation
@ast
CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation
@en
CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation
@nl
type
label
CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation
@ast
CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation
@en
CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation
@nl
prefLabel
CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation
@ast
CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation
@en
CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation
@nl
P2093
P921
P1476
CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation
@en
P2093
David G Ginzinger
Dong-Hui Chung
Mary Beth Humphrey
Mary C Nakamura
William E Seaman
P304
P356
10.4049/JIMMUNOL.171.12.6541
P407
P577
2003-12-01T00:00:00Z